ABSTRACT-The effect of majonoside-R2 on morphine and U-50,488H-induced antinociception was examined by the tail-pinch test in mice and compared with that of diazepam. Majonoside-R2 and diazepam inhibited the morphine and U-50,488H-induced antinociception, and the actions were antagonized by the benzodiazepine receptor antagonist flumazenil and the GABA-gated Cl-channel blocker picrotoxin. Diazepam but not majonoside-R2 exhibited a protective activity against convulsion caused by the GABAA antagonists bicuculline and picrotoxin. These results indicate that GABAA systems are involved in the effect of majonoside-R2 on the opioid-induced antinociception and suggest that the mechanisms of action of majonoside-R2 may differ from those of diazepam.
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Keywords: Majonoside-R2, Antinociception, GABAA-receptor Majonoside-R2, a major constituent of Vietnamese ginseng, is an ocotillol-type saponin isolated and purified from Vietnamese ginseng saponin. This ocotillol-type saponin has not been isolated from Panax ginseng, American ginseng or Sanchi ginseng (1). Our previous data demonstrated that majonoside-R2 reversed the psychological stress-induced decrease in pen tobarbital sleep to the normal level in mice and that the effect of majonoside-R2 was abolished by flumazenil, a benzodiazepine receptor antagonist (2). Moreover, recent findings in this laboratory showed that orally admin istered Vietnamese ginseng extract and crude saponin attenuated the morphine and U-50,488H-induced anti nociception and suppressed the development of mor phine tolerance (3). Taken together, it is possible that opioid and GABAA-receptor mechanisms are involved in the pharmacological action of majonoside-R2. In this study, to further test this possibility, we investigated the effects of majonoside-R2 on the morphine and U 50,488H-induced antinociception in the tail-pinch test in mice and compared them with those of diazepam.
Male 5-week-old ddY mice (Japan SLC, Shizuoka) were used for the experiments.
Majonoside-R2 was purified from the saponin fraction of Vietnamese ginseng (yield: 5.29010 of the dry material) as previously described (1). Test drugs, except diazepam, flumazenil and bicuculline, were dissolved in saline. Diazepam (Cercine(R; Takeda Chemical Industries Ltd., Osaka) was dissolved in saline containing 40010 propylene glycol. Bicuculline (Calbiochem, La Jolla, CA, USA) was dissolved in saline by adding a few drops of 1 N-HCI. All drug solutions were prepared just before starting the ex periments and administered in a constant volume of 0.1 ml/10 g body weight.
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The nociceptive response in the tail-pinch test was measured according to Haffner's method as previously reported (4). To prevent tissue damage, a cut-off time of 6 sec was selected. The latency to show nociceptive responses was measured at 30 and 15 min after morphine HCI (Dainippon Pharmaceutical Co., Ltd., Osaka) and U-50,488H
(trans-(±) 3,4-dichloro-N-methyl-N-(2-[1 pyrrolidinyl]-cyclohexyl) benzeneacetamide; Sigma Chem., Co., St. Louis, MO, USA) administration, respectively, when the effects of these opioids peaked (3).
The tail-pinch latency was expressed as the mean per centage maximum possible effect (5): o7oMPE=(post drug latency pre-drug latency)/(cut-off time-pre-drug latency) x 100.
Majonoside-R2 and diazepam were injected i.p. 30 min before morphine or U-50,488H administration.
Mor phine HCl and U-50,488H were injected subcutaneously (s.c.). Flumazenil (Anexate(X; Roche Co., Ltd., Basel, Switzerland) and picrotoxin (Sigma Chem.) were injected i.v. and i.p., respectively, just before opioid adminis tration. In our preliminary study (6), we found that majonoside-R2 (3.1-6.2 mg/kg, i.p.) and diazepam (0.5 1.0 mg/kg) caused a dose-dependent suppression of morphine (5 mg/kg, s.c.) and U-50,488H (15 mg/kg, s.c.)-induced antinociception in the tail-pinch test. Thus, in this study, we chose submaximal doses of majonoside R2 (3.1 mg/kg, i.p.) and diazepam (0.5 mg/kg, i.p.). To evaluate the protective action on bicuculline and picrotoxin-induced convulsion in mice, diazepam and majonoside-R2 were administered i.p. After 30 min, bicu culline (3 mg/kg) or picrotoxin (3 mg/kg) was admin istered s.c. and the latency to show the first generalized myoclonic seizures (characterized by quick, whole-body twitches and jerks), and mortality were recorded during an observation period of 30 (for bicuculline-induced convulsion) or 60 min (for picrotoxin-induced convul sion).
The effects of drugs on the nociceptive response were analyzed with two-way analysis of variance (ANOVA) followed by Tukey's test. The protective effects on GABAA antagonist-induced convulsion were analyzed with the Mann-Whitney test. Differences of P <0.05 were considered significant. As shown in Fig. 1 Moreover, the selective c-agonist U-50,488H-induced antinociception in the tail-pinch test was antagonized by majonoside-R2 were also observed (Fig. 2B) . Both flumazenil and picro toxin significantly blocked the effects of diazepam and majonoside-R2 on U-50,488H-induced antinociception, without changing the antinociceptive action of morphine or U-50,488H by themselves.
To further clarify whether majonoside-R2 has the simi lar pharmacological profiles to diazepam, we tested the effects of majonoside-R2 on the GABAA antagonist-in duced convulsion, and compared them with those of dia zepam. As summarized in Table 1 , diazepam (0.5 mg/kg, i.p.) but not majonoside-R2 (1.5, 3.1 and 6.2 mg/kg, i.p.), significantly delayed the onset of convulsions caused by bicuculline (3 mg/kg, s.c.) and picrotoxin (3 mg/kg, s.c.).
It has been reported that diazepam attenuates the anti nociceptive effect of opioid agonists and that the action is partially reversed by GABAA antagonists (7-9). Con sistent with these findings, the present results showed that the antinociception caused by p and K-opioid agonists in the tail-pinch test were significantly suppressed by dia zepam, and that the effect of diazepam was significantly antagonized by the benzodiazepine receptor antagonist flumazenil and the GABA-gated chloride channel blocker picrotoxin. Thus, these findings support the idea that en hancement of GABAergic transmission negatively modu lates the opioid receptor-mediated antinociception.
Previously, we reported that flumazenil significantly blocked the reversing effects of diazepam and majonoside-R2 on the psychological stress-induced decrease in pentobarbital sleep in mice (2). In this study, we also found that both flumazenil and picrotoxin com pletely blocked the antagonistic effects of majonoside-R2 on morphine and U-50,488H-induced antinociception in the tail-pinch test. Taken together, it is possible that en hancement of the function of GABAA receptor complex is at least partly involved in the pharmacological action of majonoside-R2. Although the exact mechanism of the antagonistic action of majonoside-R2 on the opioid-in duced antinociception remains unclear, majonoside-R2 does not seem to share the same mechanism of action as diazepam, since in contrast to diazepam majonoside-R2 failed to suppress convulsion caused by GABAA antago nists bicuculline and picrotoxin.
It has been demonstrated that the GABAA receptor function in the brain can be negatively or positively modulated by various neuroactive steroids (10), and that adrenalectomy attenuates the swim stress-induced in crease in neurosteroid levels not only in the plasma but also in the cortex (11). These findings suggest that neuro active steroids are in part derived from the peripheral system. Ginsenosides have been demonstrated to produce an estrogen-like effect and bind to glucocorticoid recep tors (12). Moreover, Vietnamese ginseng extract report edly produces steroid hormone-like effects that are mediated by the hypothalamus-pituitary-adrenal axis (13). Thus, it would be quite interesting to speculate that majonoside-R2 and/or its metabolites may have prop erties like a GABA agonistic neurosteroid because of the steroid-like structure of majonoside-R2. Clarification of the possible interactions between majonoside-R2 and the GABAA receptor complex and between majonoside-R2 and opioid receptors would require further investigation such as receptor binding experiments. Nevertheless, tak ing into account the data that, in contrast to diazepam, majonoside-R2 failed to block the convulsion caused by GABAA-receptor antagonists, there is a possibility that the suppressive effect of majonoside-R2 on opioid-in duced antinociception is due to its indirect action on the GABAergic systems negatively modulating the function of opioid systems.
In conclusion, the present results suggest that majonoside-R2 exhibits the attenuating action on the opioid-induced antinociception by modulating the func tion of GABAA receptor systems.
